Aug 11 (Reuters) – India is in talks to buy 50 million doses of Pfizer Inc (PFE.N) and German partner BioNTech SE’s (22UAy.DE) COVID-19 vaccine, the Wall Street Journal reported on Wednesday, citing people familiar with the matter. A Pfizer spokesperson said it was in talks with the government to supply vaccines, but declined to provide further details. The Indian health ministry did not immediately respond to Reuters request for comment. To be sure, the drugmaker has not yet sought permission for use of its vaccine in India. India rolled out one of the world’s largest vaccination drives earlier this year and has been relying heavily on the AstraZeneca (AZN.L) vaccine produced by the Serum I
Hence then, the article about india in talks to buy 50 million doses of pfizer vaccine wsj was published today ( ) and is available onEGYPT INDEPENDENT ( Egypt ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( India in talks to buy 50 million doses of Pfizer vaccine – WSJ )